Ovarian Cysts: When to Operate (Guide 2026)

Problem-Solving Guide: Ovarian Cysts – When to Operate (2026 Edition)

Managing ovarian cysts presents a complex clinical challenge that requires an evidence-based and personalized approach. The decision to surgically intervene on an ovarian cyst is never simple and must balance numerous factors, including the patient's symptoms, the cyst's sonographic characteristics, the risk of malignancy, and individual preferences. This problem-solving guide aims to outline a structured framework for healthcare professionals and to inform patients, based on the latest guidelines and current clinical consensus, looking ahead to 2026.

Understanding Ovarian Cysts: Classification and Nature

Ovarian cysts are fluid-filled sacs that develop inside or on the surface of an ovary. While most are benign and transient, their heterogeneity requires accurate classification to guide correct clinical management. The fundamental distinction is between functional cysts and pathological cysts.

• Functional Cysts: These are the most common and result from the normal process of ovulation. They are not considered neoplasms.
  • Follicular Cysts: Form when a follicle fails to release an egg or does not regress after ovulation.
  • Corpus Luteum Cysts: Develop when the corpus luteum fails to resorb and continues to grow, accumulating fluid or blood. They often regress spontaneously within a few menstrual cycles.
• Pathological Cysts: These are not related to the menstrual cycle and can persist or grow. They can be benign, borderline, or malignant.
  • Dermoid Cysts (mature cystic teratomas): Contain tissues derived from all three germ layers (skin, hair, teeth, fat, etc.). They are almost always benign.
  • Endometriomas (chocolate cysts): Associated with endometriosis, they contain old menstrual blood that takes on a brownish color.
  • Serous or Mucinous Cystadenomas: Benign tumors originating from the surface of the ovary, they can reach considerable sizes.
  • Cysts with Suspicious Characteristics: Those that show elements potentially suggesting malignancy and require careful oncological evaluation.

Diagnostic Evaluation: The Pillars of Problem Solving

Accurate evaluation is key to risk stratification and guiding therapeutic decisions. This process includes a combination of patient history, physical examination, advanced imaging, and, when indicated, tumor markers.

• Detailed Clinical History:
  • Patient's Age: A crucial factor; the risk of malignancy increases with age, especially in post-menopause.
  • Symptoms: Evaluation of the nature, intensity, and duration of pelvic pain (acute, chronic, intermittent), abdominal bloating, menstrual cycle alterations, urinary or bowel disturbances. The absence of symptoms is equally informative.
  • Gynecological and Obstetric History: Number of pregnancies, parity, use of oral contraceptives or hormone therapies.
  • Family History: Family history of ovarian, breast, or colorectal cancers, indicating a possible genetic predisposition (e.g., BRCA1/2 mutations, Lynch syndrome).
  • Personal History: Previous ovarian cysts, diagnosis of endometriosis, abdominal or pelvic surgeries.
• Physical Examination:
  • Bimanual Pelvic Exam: Evaluates the size, mobility, consistency, and tenderness of the adnexa.
  • Abdominal Exam: To rule out ascites, palpable masses, or signs of peritoneal irritation.
• Imaging:
  • Transvaginal (TVS) and Abdominal Ultrasound: This is the first-line and most important investigation for characterizing ovarian masses. The following cyst characteristics are carefully evaluated:
    • Size: The maximum diameter is a relevant factor. Cysts >5-7 cm warrant greater attention.
    • Morphology: Whether the cyst is unilocular (a single chamber) or multilocular (multiple chambers separated by septa).
    • Contents: Anechoic (simple fluid), hypoechoic (denser fluid, as in endometrioma), with internal echoes (characteristic of dermoids), or solid.
    • Solid/Papillary Components: Presence, size, and shape of any solid or papillary projections within the cyst.
    • Septa: Thickness and regularity of any septa. Thick or irregular septa can be signs of malignancy.
    • Vascularization: Evaluated using color Doppler. Irregular or very intense blood flow within solid components may indicate malignancy.
    • Presence of ascites (free fluid in the abdomen) or peritoneal nodules: Signs that may indicate neoplastic spread.
  • Pelvic Magnetic Resonance Imaging (MRI): Used when ultrasound is inconclusive, for complex cysts, or for better pre-operative characterization, especially if malignancy is suspected.
• Tumor Markers:
  • CA-125: A marker used, but with limitations. It can be elevated in benign conditions (e.g., endometriosis, fibroids, pelvic inflammations, menstruation, pregnancy) and is not always elevated in early-stage ovarian cancer. It is more informative in post-menopausal women.
  • HE4, ROMA Index: HE4 (Human Epididymis Protein 4) and the ROMA index (Risk of Ovarian Malignancy Algorithm), which combines CA-125, HE4, and patient age, can improve the accuracy in estimating the risk of malignancy, especially in women with ovarian masses.

Determining Factors for Surgical Decision

The decision to operate is a carefully considered process that integrates all collected information, following a problem-solving approach that aims to maximize patient benefit while minimizing risks.

Risk of Malignancy

This is the most critical factor and is stratified using specific tools and criteria:

• IOTA Criteria (International Ovarian Tumor Analysis): These use a set of Simple Rules or a logistic regression model (LR2/LR1) based on sonographic characteristics to classify ovarian masses as benign or malignant with high accuracy.
  • Features favoring benignity (B-features): Unilocular cyst, presence of solid components where the largest part is <7 mm, presence of acoustic shadows, smooth multilocular wall, absence of color Doppler flow.
  • Features favoring malignancy (M-features): Irregular solid components, ascites, at least 4 papillary structures, multilocular mass with a diameter >100 mm, very intense color Doppler flow.
• Risk Algorithms: Such as ROMA (Risk of Ovarian Malignancy Algorithm), which combines CA-125, HE4, and patient age to provide a risk score.
• Patient's Age: In post-menopausal women, cysts with complex or persistent characteristics have a significantly higher risk of malignancy compared to those in pre-menopause.

Symptomatology

• Persistent or severe pain: Especially if unresponsive to medical therapy, may indicate the need for cyst removal.
• Compressive symptoms: Sensation of pressure, abdominal distension, urinary disturbances (frequency, urgency) or bowel disturbances (constipation, bloating) caused by the size or position of the cyst.
• Acute symptoms:
  • Ovarian torsion: A surgical emergency characterized by acute and sudden abdominal pain, nausea, vomiting. Requires immediate intervention to attempt to save the ovary.
  • Cyst rupture: Can cause acute pain and intra-abdominal bleeding. Management can be conservative or surgical depending on the severity of bleeding and the patient's symptoms.

Cyst Characteristics (Sonographic and Clinical)

• Size: Cysts >5-7 cm, especially if persistent and with suspicious characteristics, are often candidates for removal, particularly in post-menopausal women. In pre-menopausal women, even large functional cysts can be carefully monitored.
• Persistence: Cysts that do not spontaneously regress after an observation period (e.g., 2-3 menstrual cycles for functional cysts).
• Rapid Growth: A significant increase in size in a short time is a warning sign.
• Complex Morphology: Presence of solid elements, thick and irregular septa, papillary proliferations, atypical Doppler vascularization.

Desire for Fertility

In women of childbearing age who desire pregnancy, conservative surgical interventions (cystectomy) are preferred to preserve healthy ovarian tissue and ovarian reserve, unless there is a high and proven suspicion of malignancy.

Patient Comorbidities

Pre-existing medical conditions and general health status can influence suitability for surgical intervention, requiring a thorough anesthesiological evaluation and careful consideration of operative risks.

Management Approaches: Observation vs. Surgery

Conservative Management (Monitoring)

This option is indicated for most ovarian cysts, particularly for:

• Simple, unilocular, anechoic cysts of small-to-medium size (<5-7 cm), especially in women of childbearing age.
• Cysts with low-risk characteristics for malignancy according to IOTA criteria or other validated algorithms.
• Asymptomatic cysts.

Monitoring involves periodic ultrasound checks (e.g., every 3-6 months) to assess spontaneous resolution, stability, or growth of the cyst. The use of oral contraceptives may be considered to suppress ovulation and prevent the formation of new functional cysts, but it is not proven to reduce the size of pre-existing cysts.

Surgical Management

Surgical intervention is indicated in the presence of:

• High suspicion of malignancy (cysts with high-risk sonographic characteristics and/or tumor markers).
• Persistent or severe symptoms that compromise the patient's quality of life and do not respond to conservative therapy.
• Large cysts (>7-10 cm) or rapidly growing cysts.
• Cysts with acute complications (torsion, rupture with significant hemorrhage).
• Cysts that do not regress after an adequate observation period and present not entirely reassuring characteristics.

Surgical Techniques:

• Laparoscopy: This is the preferred, minimally invasive approach for most benign cysts. It offers shorter recovery times, less post-operative pain, and fewer complications compared to laparotomy.
• Laparotomy: Open surgery, reserved for very large cysts, in cases of strong suspicion of malignancy (to allow for complete and safe staging), or in complex surgical situations.

Type of Intervention:

• Ovarian Cystectomy: Removal of only the cyst, preserving the remaining healthy ovarian tissue. It is the preferred option for benign cysts in women of childbearing age to preserve fertility and hormonal function.
• Ovariectomy/Adnexectomy: Removal of the entire ovary (and sometimes the fallopian tube). This option is considered in post-menopausal women, for very large cysts that have destroyed healthy ovarian tissue, or in the presence of a high and well-founded suspicion of malignancy.

The Individualized Decision-Making Process: Towards 2026

The final decision on "when to operate" is always the result of a thorough and shared discussion between the patient and a multidisciplinary medical team (gynecologist, radiologist, pathologist, gynecologic oncologist if necessary). It is a problem-solving process that weighs the risks and benefits of each therapeutic option, taking into account the patient's values, expectations, and preferences. Guidelines for 2026 will continue to emphasize the importance of pre-operative diagnostic accuracy, the use of validated risk algorithms, and an increasingly personalized approach, with a growing focus on mini-invasive surgical techniques and the preservation of fertility and ovarian function when clinically appropriate.

Conclusion

Ovarian cysts represent a broad category of gynecological conditions requiring careful evaluation. The choice to intervene surgically is guided by a meticulous clinical, radiological, and laboratory analysis, with the primary objective of ruling out malignancy and alleviating symptoms, while preserving ovarian function wherever possible. This problem-solving framework provides a structured approach to navigating the complexities of ovarian cysts, ensuring optimal, informed, and patient-centered care, in line with current and future best practices.